(Q35592279)
Statements
1 reference
Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib (English)
1 reference
William Pao
1 reference
Mark G Kris
1 reference
Camelia S Sima
1 reference
Melissa L Johnson
1 reference
Greg J Riely
1 reference
Naiyer A Rizvi
1 reference
Christopher G Azzoli
1 reference
Michelle S Ginsberg
1 reference
Vincent A Miller
1 reference
1 June 2011
1 reference
1 reference
6
1 reference
6
1 reference
1128-1131
1 reference
Identifiers
1 reference
1 reference
1 reference